OREANDA-NEWS. On 21 April 2008 was announced, that Grindeks JSC is expanding its activities in the former soviet republics members of Commonwealth of Independent States by opening new representative office in Uzbekistan. The new representative office will have been cooperating with medicines administrating state authorities, Uzbekistan’s companies engaged in pharmaceutical and medicinal products wholesale and retail business, as well as providing drug registration processes and medicaments marketing.

Jвnis Romanovskis, Chairman of the Management Board of Grindeks JSC, points out: „Former soviet republics members of CIS are, strategically, the most important markets for final dosage forms of medicines manufactured by Grindeks, where the demand for our products, especially for Mildronate®, is increasing every year. Uzbekistan is a perspective developing market, and our new representative office will facilitate to make the most of its resources.”

In 2007, export volume to Uzbekistan exceeded half a million LVL. Currently, 10 of our products are registered in Uzbekistan.

The Head of Representative Office is Mastura Kutmatova, and there are totally three employees in the Representative Office.